Reactivation of hepatitis B virus infection in pancreatic cancer: A case report

Japanese Journal of Clinical Oncology

Volumn 32, Issue 12, 2002, Pages 543-545

  Öksüzoǧlu, Berna ^a,b   Kiliçkap, Saadettin ^a   Yalcin, Şuayib ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Hacettepe University ^*  (Turkey)

Author keywords

Chemotherapy; Hepatitis B virus; Pancreatic cancer; Reactivation

Indexed keywords

CISPLATIN; GEMCITABINE; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; ANTINEOPLASTIC AGENT;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DNA DETERMINATION; DRUG WITHDRAWAL; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LABORATORY TEST; LAPAROTOMY; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; NONHUMAN; PANCREAS CANCER; PRACTICE GUIDELINE; VIRUS CARRIER; VIRUS REACTIVATION; ADENOCARCINOMA; BLOOD; HEPATITIS B; HEPATITIS B VIRUS; LIVER TUMOR; METASTASIS; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; VIRUS ACTIVATION;

EID: 0036987779     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyf113     Document Type: Article

References (12)

1. Perrillo RP. Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001;120:1009-22.
2. Yalçin Ş, Kars A, Sökmensüer C, Atahan L. Extrahepatic Hodgkin's disease with intrahepatic cholestasis. Report of two cases. Oncology 1999;57:83-5.
3. Nakamura Y, Motokura T, Fujita A, Yamashita T, Ogata E. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies: Survey in Japan 1987-1991. Cancer 1996;78:2210-5.
4. Yalçin Ş, Şahin A, Yalçin B, Altinok G. Nitrofurantoin toxicity to both lungs and liver: A case report. Liver 1997;17:166-7.
5. Alexopoulos CG, Vaslamatzis M, Hatzidimitriou G. Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumors. Br J Cancer 1999;81: 69-74.
6. Yeo W, Chan PKS, Zhang S, Ho WM, Steinberg JL, Tam JS, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy. J Med Virol 2000;62:299-307.
7. Lok AFS, Liang RHS, Chiu EKW, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 1991;100:182-8.
8. Hoofnagle JH, Dusheiko GM, Schafer DF, Jones EA, Micetech KC, Young RC, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982;96:447-9.
9. Soh LT, Ang PT, Sing I, Chua EJ, Ong YW. Fulminant hepatic failure in non-Hodgkin's lymphoma patients treated with chemotherapy. Eur J Cancer 1992;28:1338-9.
10. Pinto PC, Hu E, Bernstein-Singer M, Pinter-Brown L, Govindrajan S. Acute hepatic injury after withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 1990;65:878-84.
11. Dienstag JL, Schiff ER, Wright TL. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-63.
12. Endo T, Sakai T, Fujimoto K, Yamamoto S, Takashima S, Haseyama Y, et al. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplant 2001;27:433-6.